Mentice

Mentice Intangible Assets

The Intangible Assets of Mentice (MNTC.ST) as of Oct 28, 2026 is 68.59 M SEK. In the previous year, Intangible Assets was 69.03 M SEK — a change of -0.62% (lower).

Intangible Assets

68.59 MSEK

YoY

-0.62%

Last updated:

Intangible Assets of Mentice is 2024 68.59 M SEK. Intangible Assets of Mentice was 2023 69.03 M SEK. It decreases by -0.62% lower compared to the previous year.

The Mentice Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
26.29 M SEK
Jan 1, 2018
33.40 M SEK
Jan 1, 2019
30.95 M SEK
Jan 1, 2020
58.61 M SEK
Jan 1, 2021
63.71 M SEK
Jan 1, 2022
82.35 M SEK
Jan 1, 2023
69.03 M SEK
Jan 1, 2024
68.59 M SEK
The Mentice Intangible Assets history
YEARIntangible AssetsYoY
68.59 MSEK-0.62%
69.03 MSEK-16.18%
82.35 MSEK+29.25%
63.71 MSEK+8.71%
58.61 MSEK+89.34%
30.95 MSEK-7.32%
33.40 MSEK+27.06%
26.29 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Mentice Stock analysis

What does Mentice do? Mentice AB provides software and hardware simulation solutions for endovascular therapies, targeting healthcare professionals and the medical device industry. The company's solutions are scientifically validated and designed to help users acquire, retain, and enhance procedural skills in neurovascular, cardiovascular, and peripheral interventions. Mentice AB generates revenue through the sale of its simulation products and related services, with key buyers including healthcare providers and medical device manufacturers. The company operates globally, serving clients across multiple healthcare segments that require advanced training tools for minimally invasive procedures. Mentice AB's business model focuses on delivering scientifically validated simulation tools that address skill development needs in complex medical procedures. The firm's product offerings cater to both healthcare institutions seeking to train staff and medical device companies requiring validation tools for their products. By specializing in endovascular therapy simulations, Mentice AB serves a niche market with high demand for precise procedural training solutions. The company's global presence allows it to reach clients in various regions seeking advanced medical simulation technology. The company's revenue streams come from the sale of simulation software and hardware systems alongside ongoing service contracts. Healthcare providers purchase these solutions to improve staff competency in endovascular procedures, while medical device manufacturers use them to validate device performance in simulated environments. Mentice AB's solutions are specifically developed for the medical device industry and healthcare providers, creating a dual revenue stream from both sectors. The firm's focus on scientifically validated tools ensures strong market positioning within specialized medical training segments. Mentice is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Mentice stock

Intangible Assets of Mentice is 68.59 M SEK in 2024.

Intangible Assets of Mentice changed from 69.03 M SEK to 68.59 M SEK, representing a -0.62% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Mentice since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Mentice historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Mentice

All Key Metrics — Mentice